High-Tech Microscope Constructed for Low Cost
|
By LabMedica International staff writers Posted on 08 Dec 2014 |

Image: The low cost microscope system constructed to perform multiple simultaneous time-lapse studies on various cell types (Photo courtesy of Adam Lynch).
The direct visualization of cells for the purpose of studying their motility has typically required expensive microscopy equipment; however, recent advances in digital sensors mean that it is now possible to image cells for a fraction of the price of a standard microscope.
The development and performance of an expandable cell motility system has been described that employs inexpensive, commercially available digital Universal Serial Bus (USB) microscopes to image various cell types using time-lapse and perform tracking assays.
Scientists at Brunel University (Uxbridge, UK) constructed the apparatus from cheaply bought materials. Various lighting sources were tested, and ultimately a light-emitting diode (LED) strip desk lamp was selected. An incubation chamber was developed to fit over the top of the stage and the chamber was made from transparent acrylic to allow visualization inside.
The three microscopes used were identical models (VMS-004D, Veho; Southampton, UK) in order to prevent any discrepancies. These microscopes use a complementary metal–oxide–semiconductor (CMOS) image sensor with 1.3 mega-pixel resolution. Magnification has two set levels, from approximately ×20 minimum to around ×400 maximum, achieved using a focusing wheel. To enhance stability, magnification and to allow for observation of live samples in liquid (cells) the microscopes were inverted.
The imaging capability of the system was compared to a conventional inverted microscope fitted with a 1.3 megapixel camera. The highest magnification on the conventional microscope was greater than the constructed system, but the maximum pixel resolution of images was the same. Spatial resolution on the conventional microscope was higher and intra-cellular detail could be seen at the highest magnification that could not be distinguished in the innovative system when images were enlarged to match the size.
The authors concluded that the novel cell tracking system had the ability to perform multiple simultaneous time-lapse studies on various cell types. Due to its low-cost, portability and commercially available components they believe that this system has the potential to enable time-lapse studies by non-specialist departments, and may be a practical solution for scientists with limited financial resources. The study was published on August 14, 2014, in the journal Public Library of Science ONE.
Related Links:
Brunel University
Veho
The development and performance of an expandable cell motility system has been described that employs inexpensive, commercially available digital Universal Serial Bus (USB) microscopes to image various cell types using time-lapse and perform tracking assays.
Scientists at Brunel University (Uxbridge, UK) constructed the apparatus from cheaply bought materials. Various lighting sources were tested, and ultimately a light-emitting diode (LED) strip desk lamp was selected. An incubation chamber was developed to fit over the top of the stage and the chamber was made from transparent acrylic to allow visualization inside.
The three microscopes used were identical models (VMS-004D, Veho; Southampton, UK) in order to prevent any discrepancies. These microscopes use a complementary metal–oxide–semiconductor (CMOS) image sensor with 1.3 mega-pixel resolution. Magnification has two set levels, from approximately ×20 minimum to around ×400 maximum, achieved using a focusing wheel. To enhance stability, magnification and to allow for observation of live samples in liquid (cells) the microscopes were inverted.
The imaging capability of the system was compared to a conventional inverted microscope fitted with a 1.3 megapixel camera. The highest magnification on the conventional microscope was greater than the constructed system, but the maximum pixel resolution of images was the same. Spatial resolution on the conventional microscope was higher and intra-cellular detail could be seen at the highest magnification that could not be distinguished in the innovative system when images were enlarged to match the size.
The authors concluded that the novel cell tracking system had the ability to perform multiple simultaneous time-lapse studies on various cell types. Due to its low-cost, portability and commercially available components they believe that this system has the potential to enable time-lapse studies by non-specialist departments, and may be a practical solution for scientists with limited financial resources. The study was published on August 14, 2014, in the journal Public Library of Science ONE.
Related Links:
Brunel University
Veho
Latest Technology News
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
- Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
- Online Tool Supports Family Screening for Inherited Cancer Risk
Channels
Clinical Chemistry
view channel
Urine-Based Test Shows Promise for Autism Screening in Children
Autism spectrum disorder (ASD) is commonly diagnosed through behavioral assessments, which can involve long waits that delay intervention. Earlier identification is linked to better developmental outcomes,... Read more
Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis
Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read moreMolecular Diagnostics
view channel
Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests
Colorectal cancer is the second-leading cause of cancer death in the United States and claimed an estimated 55,000 lives in 2026. Incidence is rising among adults younger than 50, even as overall mortality... Read more
Digital PCR Assays Support Surveillance of Bundibugyo Ebolavirus Outbreak
QIAGEN (Venlo, Netherlands) has introduced two custom-designed research-use-only (RUO) QIAcuity dPCR assays to support infectious disease research and surveillance connected to the Bundibugyo ebolavirus outbreak.... Read more
Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer
Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channel
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) affects nearly 3 million people in the United States and its prevalence continues to rise. Medications that target tumor necrosis factor (TNF)-alpha are widely used, but... Read moreMicrobiology
view channel
Gut Microbiome Signatures Help Identify Risk of IBD Progression
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic relapsing inflammatory disorder of the gastrointestinal tract with highly variable outcomes.... Read more
FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets
Clinical guidelines support testing based on patient presentation in suspected gastrointestinal infections, yet available technologies have often forced laboratories to choose between panels that are too... Read morePathology
view channel
AI-Powered Atlas Maps Immune Structures Linked to Cancer Outcomes
Tertiary lymphoid structures are emerging as important indicators of antitumor immunity, but their heterogeneity and spatial context within tumors remain difficult to capture through routine diagnostics.... Read more
AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy
Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read moreIndustry
view channelWerfen and Oxford Nanopore Collaborate on Transplant Assay Development
Werfen (Barcelona, Spain), a global specialized diagnostics company, has announced a strategic collaboration with Oxford Nanopore Technologies (Oxford, UK), which develops nanopore-based sequencing technology,... Read more








